Stephen Aselage
Director/Board Member at BIOCRYST PHARMACEUTICALS, INC.
Net worth: 263 490 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gary Lyons | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 21 years |
R. Clifton | M | 51 | 1 years | |
Chris Cline | M | 40 | 10 years | |
Helen Thackray | M | 55 | 5 years | |
John Orwin | M | 62 |
SangStat Medical Corp.
| 10 years |
Nancy Hutson | M | 74 | 12 years | |
George Abercrombie | M | 69 | 13 years | |
Randy Meier | M | 65 | 18 years | |
Jeffrey Meckler | M | 57 | 10 years | |
Jon Stonehouse | M | 63 | 17 years | |
Anthony Doyle | M | 44 | 4 years | |
Eric Dube | M | 51 | 5 years | |
Theresa Heggie | F | 63 | 6 years | |
Sandra Calvin | F | 59 | 10 years | |
Amy McKee | M | 52 | 3 years | |
A. Sanders | F | 60 | 2 years | |
Philip Lo Scalzo | M | - | 17 years | |
Ryan Arnold | M | - | 2 years | |
Elizabeth Reed | F | 53 | 7 years | |
Steven Galson | M | 67 | 3 years | |
Jason Kneeland | M | - | 7 years | |
Alane Barnes | F | 58 | 18 years | |
Sandra E. Poole | F | 60 | 5 years | |
Alan Levin | M | 62 | 4 years | |
William P. Sheridan | M | 69 | 16 years | |
Tanya Hayden | F | 44 | 3 years | |
Stuart Bunting | M | - | 16 years | |
Ron Squarer | M | 57 | 7 years | |
Jefferson E. Davis | M | 57 | 9 years | |
Pravin Soni | M | - |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | 11 years |
Roy Baynes | M | 69 | 8 years | |
Ruth Williams-Brinkley | F | 72 | 3 years | |
Henry Fuchs | M | 66 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 25 years |
Vin Milano Milano | M | 60 | 3 years | |
Suzanne Bruhn | M | 60 | 4 years | |
Tim Coughlin | M | 57 | 9 years | |
Donald Joseph | M | 70 | 6 years | |
Thomas Madden | M | - |
Acuitas Therapeutics, Inc.
Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Acuitas Therapeutics is a private biotechnology company based in Vancouver, Canada that specializes in developing delivery systems for nucleic acid therapeutics based on lipid nanoparticles. The Canadian company partners with pharmaceutical and biotechnology companies, academic institutes, and non-governmental organizations to advance nucleic acid therapeutics into clinical trials and the marketplace. Acuitas Therapeutics has agreements in place with several partners to use its proprietary lipid nanotechnology in the development of COVID-19 vaccines, including Pfizer/BioNTech for Comirnaty®. The CEO of the company is Thomas Madden. | - |
Charles Gayer | M | 53 | 9 years | |
Jula Inrig | M | 49 | 2 years | |
Renee Carroll | F | - | 4 years | |
Catherine Collier Kyroulis | F | - | - | |
Jinky Ang Rosselli | F | - | 9 years | |
Peter Heerma | M | 53 | 5 years | |
Eduardo Von Pervieux | M | - | 16 years | |
Stephanie Angelini | F | - | 6 years | |
Brad Glasscock | M | - | 12 years | |
Robert Armstrong | M | - |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | - |
Salisa Hauptmann | F | - | 3 years | |
Esther van den Boom | F | 45 |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | - |
Casey Logan | M | 52 | 6 years | |
Kim Tharaldsen | F | - | 6 years | |
Robert Clayton Fletcher | M | 61 | 1 years | |
Rod M. Saponjic | M | - |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | - |
Bill Rote | M | 61 | 7 years | |
Yarlagadda S. Babu | M | 71 | 36 years | |
John D. Bluth | M | - | 5 years | |
Philip George | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Martin Shkreli | M | 41 |
Desert Gateway, Inc.
Desert Gateway, Inc. Financial ConglomeratesFinance Desert Gateway, Inc. operates as a capital pool company. It is presently a development stage company seeking a potential acquisition of or merger with a yet to be identified business opportunity. The company was founded on February 8, 2008 and is headquartered in Bartlesville, OK.
Retrophin LLC
Retrophin LLC BiotechnologyHealth Technology Retrophin, Inc. provides biotechnology services. It is a biotechnology company dedicated to developing drugs for rare and life-threatening diseases. The company was founded in 2011 and is headquartered in New York, NY. | 6 years |
Robert Wilson | M | 54 |
Desert Gateway, Inc.
Desert Gateway, Inc. Financial ConglomeratesFinance Desert Gateway, Inc. operates as a capital pool company. It is presently a development stage company seeking a potential acquisition of or merger with a yet to be identified business opportunity. The company was founded on February 8, 2008 and is headquartered in Bartlesville, OK. | 5 years |
Jeff Ajer | M | 61 |
SangStat Medical Corp.
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 21 years |
Christopher Schelling | M | 48 | 13 years | |
Thomas Staab | M | 56 | 9 years | |
Steven Gary Richardson | M | 70 |
Desert Gateway, Inc.
Desert Gateway, Inc. Financial ConglomeratesFinance Desert Gateway, Inc. operates as a capital pool company. It is presently a development stage company seeking a potential acquisition of or merger with a yet to be identified business opportunity. The company was founded on February 8, 2008 and is headquartered in Bartlesville, OK. | 3 years |
Harry Palmin | M | 54 | 6 years | |
Jean-Jacques Bienaimé | M | 70 |
SangStat Medical Corp.
| 4 years |
Dan Spiegelman | M | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 16 years |
Bill Donovan | M | 71 |
University of Notre Dame
| 6 years |
Hubert Birner | M | 57 | 2 years | |
Clint D. Gibler | M | 71 |
University of Notre Dame
| 6 years |
Charles J. Dougherty | M | 75 |
University of Notre Dame
| 2 years |
Laura Clague | F | 64 | 8 years | |
Gerald Eugene O'Shaughnessy | M | 75 |
University of Notre Dame
| 7 years |
Fred Cohen | M | 67 | 6 years | |
Jason Amello | M | 55 | 6 years | |
David Kreuter | M | - |
University of Notre Dame
| 7 years |
Tom C. Gores | M | - |
University of Notre Dame
| 7 years |
Jerry Cacia | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 28 years |
Michelle Griffin | F | 58 | 6 years | |
Kevin M. Butler | M | 68 |
University of Notre Dame
| 6 years |
Cornelius E. Golding | M | 76 | - | |
Steven Shak | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
Brian Lundstrom | M | 61 |
SangStat Medical Corp.
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
John Kozarich | M | 74 | 5 years | |
Margaret E. Valeur-Jensen | M | 67 | - | |
John M. Whiting | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 years |
Louis C. Drapeau | M | 79 | 3 years | |
John F. Gaither | M | 74 |
University of Notre Dame
| 7 years |
Richard E. Leigh | M | 64 | 1 years | |
Marc L. Panoff | M | 53 | 1 years | |
William Young | M | 79 | 5 years | |
Ken Bate | M | 73 | 7 years | |
Christopher Starr | M | 71 | 9 years | |
John Dunn | M | 72 | 6 years | |
Tom McIntyre | M | - |
University of Notre Dame
| 6 years |
Kenneth Lee | M | 76 | 12 years | |
V. Lawlis | M | 72 | 17 years | |
Michael Grey | M | 71 | 16 years | |
Luc Marengère | M | 59 | 2 years | |
Michael Jones | M | 54 | 13 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 99 | 99.00% |
Canada | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephen Aselage
- Personal Network